XML 38 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Compensation Plans
12 Months Ended
Dec. 31, 2022
Stock Compensation Plans [Abstract]  
Stock Compensation Plans
13 - Stock Compensation Plans

Equity Incentive Plans


Since 1996, we have maintained an Equity Incentive Plan for Employees. During 2019, we adopted a plan that made a total of 4,500,000 shares of Class A common stock available for issuance to employees of our subsidiaries and affiliates. The plan provides for the granting of awards by our board of directors in the form of stock options, stock appreciation rights, restricted stock or any combination of the above. The plan provides that stock options may become exercisable up to five years from their date of grant, with an option price not less than fair market value on the date preceding the date of grant. We have not granted any stock appreciation rights.


Since 1996, we have maintained an Equity Incentive Plan for Directors. During 2019, we adopted a plan that made 500,000 shares of Class A common stock available for issuance to our directors and the directors of our subsidiaries and affiliates. We may make awards in the form of stock options. The plan also provides for the issuance of 500 shares of restricted stock on the first business day of January in each year to each of our directors and each director of Donegal Mutual who does not serve as one of our directors. We issued 8,500 shares of restricted stock on January 4, 2022 under our director plan. We issued 10,000 shares of restricted stock on January 4, 2021 under our director plan. We issued 8,500 shares of restricted stock on January 2, 2020 under our director plan.


No further shares are available for future option grants for plans in effect prior to 2019.


We measure all share-based payments to employees, including grants of employee stock options, using a fair-value-based method and record such expense in our results of operations. In determining the expense we record for stock options granted to directors and employees of our subsidiaries and affiliates, we estimate the fair value of each option award on the date of grant using the Black-Scholes option pricing model. The significant assumptions we utilize in applying the Black-Scholes option pricing model are the risk-free interest rate, expected term, dividend yield and expected volatility. The risk-free interest rate is the implied yield currently available on U.S. Treasury zero coupon issues with a remaining term equal to the expected term used as the assumption in the model. We base the expected term of an option award on our historical experience for similar awards. We determine the dividend yield by dividing the per share dividend by the grant date stock price. We base the expected volatility on the volatility of our stock price over a historical period comparable to the expected term.



The weighted-average grant date fair value of options we granted during 2022 was $1.48. We calculated this fair value based upon a risk-free interest rate of 3.91%, an expected life of three years, an expected volatility of 22% and an expected dividend yield of 5%.


The weighted-average grant date fair value of options we granted during 2021 was $1.21. We calculated this fair value based upon a risk-free interest rate of 0.91%, an expected life of three years, an expected volatility of 20% and an expected dividend yield of 4%.


The weighted-average grant date fair value of options we granted during 2020 was $1.15. We calculated this fair value based upon a risk-free interest rate of 0.20%, an expected life of three years, an expected volatility of 20% and an expected dividend yield of 4%.


We charged compensation expense for our stock compensation plans against income before income taxes of $818,853, $965,701 and $1.1 million for the years ended December 31, 2022, 2021 and 2020, respectively, with a corresponding income tax benefit of $171,959, $202,797 and $229,698. At December 31, 2022 and 2021, our total unrecognized compensation cost related to non-vested share-based compensation granted under our stock compensation plans was $1.7 million and $1.5 million, respectively. We expect to recognize this cost over a weighted average period of 2.1 years.


During 2022, we received cash from option exercises under all stock compensation plans of $17.4 million. We realized actual tax benefits for the tax deductions from option exercises of share-based compensation of $360,452 for 2022. During 2021, we received cash from option exercises under all stock compensation plans of $12.3 million. We realized actual tax benefits for the tax deductions from option exercises of share-based compensation of $438,850 for 2021. During 2020, we received cash from option exercises under all stock compensation plans of $17.5 million. We realized actual tax benefits for the tax deductions from option exercises of share-based compensation of $302,901 for 2020.


Information regarding activity in our stock option plans follows:
 
   
Number of Options
   
Weighted-Average Exercise
Price Per Share
 
Outstanding at December 31, 2019
   
10,435,990
   
$
15.09
 
Granted - 2020
   
935,099
     
14.45
 
Exercised - 2020
   
(1,294,606
)
   
13.52
 
Forfeited - 2020
   
(303,908
)
   
15.23
 
Expired - 2020
    (78,223 )     13.64  
Outstanding at December 31, 2020
   
9,694,352
     
15.24
 
Granted - 2021
   
906,500
     
14.39
 
Exercised - 2021
   
(946,646
)
   
13.00
 
Forfeited - 2021
   
(404,664
)
   
15.69
 
Expired - 2021
    (1,139,816 )     16.40  
Outstanding at December 31, 2021
   
8,109,726
   
15.22
 
Granted - 2022
   
956,600
     
14.08
 
Exercised - 2022
   
(1,202,806
)
   
14.50
 
Forfeited - 2022
   
(545,618
)
   
15.35
 
Expired - 2022
   
(935,723
)
 

16.81
 
Outstanding at December 31, 2022
   
6,382,179
   
$
14.94
 
Exercisable at:
               
December 31, 2020
   
7,786,934
   
$
15.42
 
December 31, 2021
   
6,297,849
   
$
15.43
 
December 31, 2022
   
4,627,630
   
$
15.21
 


Shares available for future option grants at December 31, 2022 totaled 1.4 million shares under all plans.


The following table summarizes information about stock options outstanding at December 31, 2022:
 
Grant Date
 
Exercise Price
   
Number of Options Outstanding
 
Weighted-Average
Remaining
Contractual Life
 
Number of Options Exercisable
 
December 19, 2013
   
15.90
     
1,492,596
 
1.0 years
   
1,492,596
 
December 18, 2014
   
15.80
     
979,839
 
2.0 years
   
979,839
 
December 20, 2018
   
13.69
     
497,470
 
1.0 years
   
497,470
 
December 19, 2019
   
14.98
     
868,050
 
2.0 years
   
868,050
 
December 17, 2020
   
14.43
     
755,424
 
3.0 years
   
503,611
 
January 4, 2021
   
14.07
     
10,000
 
3.0 years
   
6,667
 
December 16, 2021
   
14.39
     
825,200
 
4.0 years
   
275,064
 
February 9, 2022
   
14.15
     
3,000
 
4.1 years
   
1,000
 
April 18, 2022
   
13.28
     
10,000
 
4.3 years
   
3,333
 
December 15, 2022
   
14.09
     
940,600
 
5.0 years
   
 
   
Total
     
6,382,179
       
4,627,630
 

Employee Stock Purchase Plan


Since 1996, we have maintained an Employee Stock Purchase Plan. During 2011, we adopted a plan that made 300,000 shares of our Class A common stock available for issuance, which we amended in 2019 to make 500,000 shares of our Class A common stock available for issuance. The 2011 plan expired during 2021. During 2021, we adopted a new plan that made 500,000 shares of our Class A common stock available for issuance and extends over a 10-year period. The plan provides for shares to be offered to all eligible employees at a purchase price equal to the lesser of 85% of the fair market value of our Class A common stock on the last day before the first day of each enrollment period (June 1 and December 1 of each year) under the plan or 85% of the fair market value of our Class A common stock on the last day of each subscription period (June 30 and December 31 of each year).


A summary of plan activity follows:
 
   
Shares Issued
 
   
Price
   
Shares
 
January 1, 2020
   
12.28
     
20,424
 
July 1, 2020
   
12.09
     
22,662
 
January 1, 2021
   
11.96
     
23,336
 
July 1, 2021
   
11.88
     
24,619
 
January 1, 2022
   
12.15
     
24,907
 
July 1, 2022
   
11.56
     
23,454
 


On January 1, 2023, we issued 26,545 shares at a price of $12.07 per share under this plan.

Agency Stock Purchase Plan


Since 1996, we have maintained an Agency Stock Purchase Plan. During 2018, we adopted a plan that made 350,000 shares of our Class A common stock available for issuance to agents of our insurance subsidiaries and Donegal Mutual. During 2021, we amended the 2018 plan to make 400,000 shares of our Class A common stock available for issuance. The 2018 plan expired in 2021. During 2021, we adopted a new plan that made 500,000 shares of our Class A common stock available for issuance to agents of our insurance subsidiaries and Donegal Mutual. The plan permits an agent to invest up to $12,000 per subscription period (April 1 to September 30 and October 1 to March 31 of each year) under various methods. We issue stock at the end of each subscription period at a price equal to 90% of the average market price during the last ten trading days of each subscription period. During 2022, 2021 and 2020, we issued 104,393, 99,828 and 101,647 shares, respectively, under this plan. The expense we recognized under this plan was not material.